Schrödinger, Inc.(SDGR) Stock Research - Grey Stern Research

Schrödinger, Inc. (SDGR) Stock Analysis

$20.63 (-7.20%)

SDGR Financial Performance


Use the table below to view Schrödinger, Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q3 - 2024

Metric Value Ranking among Peers
Price $20.63 -
52 Week Low $16.67 -
52 Week High $38.00 -
Market Cap $1.5 Billion 8/11
Gross Margin 50% 7/11
Profit Margin -100% 11/11
EBITDA margin -194% 11/11
Q3 - 2024 Revenue $35.3 Million 11/11
Q3 - 2024 Earnings -$38.1 Million 10/11
Q3 - 2024 Free Cash Flow -$34.6 Million 9/11
Trailing 4 Quarters Revenue $193.3 Million 11/11
Trailing 4 Quarters Earnings -$177.6 Million 8/11
Quarterly Earnings Growth 39% 8/11
Annual Earnings Growth -261% 9/11
Quarterly Revenue Growth -17% 11/11
Annual Revenue Growth 31% 1/11
Cash On Hand $160.4 Million 10/11
Short Term Debt $16.9 Million 3/11
Long Term Debt $103.3 Million 5/11

Schrödinger, Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Schrödinger, Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE -1.00 5/11
PS 7.77 4/11
PB 3.34 4/11
PC 9.36 6/11
Liabilities to Equity 0.49 6/11
ROA -0.27 9/11
ROE -0.40 9/11
Current Ratio 3.04 6/11
Quick Ratio 1.77 5/11
Long Term Debt to Equity 0.23 5/11
Debt to Equity 0.27 5/11
Burn Rate 3.45 7/11
Cash to Cap 0.11 6/11
CCR 0.91 3/11
EV to EBITDA -21.36 8/11
EV to Revenue 7.56 4/11

Company Details

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

CEO: Dr. Ramy Farid

Website: https://www.schrodinger.com

Address: 120 WEST 45TH STREET, 17TH FLOOR New York City, NEW YORK

Exchange: NASDAQ Global Select

Industry: Health Information Services

Schrödinger, Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Schrödinger, Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
HealthEquity, Inc. HQY $8.8 Billion
Veeva Systems Inc. VEEV $37.5 Billion
Teladoc Health, Inc. TDOC $1.9 Billion
R1 RCM Inc. RCM $6.0 Billion
Progyny, Inc. PGNY $1.3 Billion
10x Genomics, Inc. TXG $1.8 Billion
Accolade, Inc. ACCD $285.1 Million
American Well Corporation AMWL $143.2 Million
Certara, Inc. CERT $1.7 Billion
Doximity, Inc. DOCS $10.3 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
SDGR Income Statements
Quarter Year Revenue Earnings
Q3 2024 $ 35.3 Million -$38.1 Million
Q2 2024 $ 47.3 Million -$54.0 Million
Q1 2024 $ 36.6 Million -$54.7 Million
Q4 2023 $ 74.1 Million -$30.7 Million
Q3 2023 $ 42.6 Million -$62.0 Million
Q2 2023 $ 35.2 Million $4.3 Million
Q1 2023 $ 64.8 Million $129.1 Million
Q4 2022 $ 56.8 Million -$27.2 Million

View All

SDGR Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q3 2024 $160.4 Million $669.3 Million $120.1 Million $449.4 Million
Q2 2024 $112.3 Million $688.4 Million $123.9 Million $474.0 Million
Q1 2024 $130.2 Million $737.8 Million $125.9 Million $513.7 Million
Q4 2023 $155.3 Million $803.0 Million $127.9 Million $548.6 Million
Q3 2023 $249.4 Million $794.1 Million $129.0 Million $563.6 Million
Q2 2023 $286.0 Million $841.6 Million $121.2 Million $611.2 Million
Q1 2023 $233.2 Million $838.8 Million $115.9 Million $590.3 Million
Q4 2022 $90.5 Million $688.6 Million $116.5 Million $447.9 Million

View All

SDGR Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2024 -$34.6 Million -$1.3 Million $57.8 Million
Q2 2024 -$54.7 Million -$1.0 Million -$22.5 Million
Q1 2024 -$43.4 Million -$4.1 Million -$26.2 Million
Q4 2023 -$39.7 Million -$2.5 Million -$94.5 Million
Q3 2023 -$54.9 Million -$4.9 Million -$35.4 Million
Q2 2023 -$20.9 Million -$2.4 Million $53.3 Million
Q1 2023 -$34.7 Million -$3.6 Million $142.0 Million
Q4 2022 -$26.3 Million -$1.3 Million -$12.9 Million

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions